Trial Profile

A pilot study of STENTYS Drug-Eluting Stents in Patients with total occlusion of a coronary artery

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Oct 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sirolimus (Primary)
Indications Coronary artery disease; Coronary artery restenosis
Focus Pharmacodynamics
Acronyms SPACIOUS

Most Recent Events

31 Oct 2018 New trial record
25 Sep 2018 Final results will be available during TCT, as reported in an abstract presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
25 Sep 2018 Results presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com